Matthew P. Young
2015
In 2015, Matthew P. Young earned a total compensation of $3.2M as Executive Vice President and CFO at Jazz Pharmaceuticals, a 6% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $225,000 |
|---|---|
| Option Awards | $1,153,778 |
| Salary | $465,769 |
| Stock Awards | $1,344,582 |
| Other | $3,710 |
| Total | $3,192,839 |
Young received $1.3M in stock awards, accounting for 42% of the total pay in 2015.
Young also received $225K in non-equity incentive plan, $1.2M in option awards, $465.8K in salary and $3.7K in other compensation.
Rankings
In 2015, Matthew P. Young's compensation ranked 2,945th out of 13,638 executives tracked by ExecPay. In other words, Young earned more than 78.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,945 out of 13,638 | 78th |
Division Manufacturing | 1,038 out of 5,190 | 80th |
Major group Chemicals And Allied Products | 385 out of 1,854 | 79th |
Industry group Drugs | 301 out of 1,528 | 80th |
Industry Pharmaceutical Preparations | 239 out of 1,182 | 80th |
Source: SEC filing on June 20, 2017.
Young's colleagues
We found four more compensation records of executives who worked with Matthew P. Young at Jazz Pharmaceuticals in 2015.